MENU
PYXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pyxis Oncology (PYXS) Ownership - Who owns Pyxis Oncology?
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 221-9059
Employees
50
Web
https://www.pyxisoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
76.51M
P/E Ratio
N/A
Total Cash
144.82M
Projected Growth
N/A
Total Debt
20.54M
Revenue
16.15M
Risk (Beta)
0.81
Dividend Yield
N/A
Total Cash/Share
2.34
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PYXS
Capitalization
76.5M
P/E Ratio
N/A
Risk (Beta)
0.81
Dividend Yield
N/A
Total Cash
145M
Total Cash/Share
2.34
Total Debt
20.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
16.1M
ROE
N/A
Book Value
154M
P/B Ratio
0.77
Cash Flow
N/A
Earnings
-1.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
59K
Current Ratio
7.33
Current Revenue Per Employee
316588.25
Dividends Per Share - Security
N/A
EBITDA
-64.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
97.06
Revenue To Assets
-30.03
Shares Held By Institutions
61.3M
Shares Outstanding - Current
61.9M
Total Liabilities
41.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-20.833
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 221-9059
Employees
50
Web
https://www.pyxisoncology.com